MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/0115733971257151230919095431

Медицинская библиотека · Current rheumatology reviews · 2024

No Correlation between Anti-drug Antibodies and Therapeutic Response in Tunisian Patients with Chronic Inflammatory Diseases Treated by TNF Blockers.

Bouden Selma, Laadhar Lilia, Soua Jihene, Ben Messaoud Meriam, Rouached Leila, Ayadi Imene, Saidane Olfa, Ben Tekaya Aicha, Mahmoud Ines, Rekik Sonia, Srairi Héla Sahli, Tekaya Rawdha, Bellakhal Syrine, Fekih Monia, Abdelmoula Leila, Kallel Maryem

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

INTRODUCTION

Tumor necrosis factor alpha (TNF alpha) blockers such as infliximab (IFX) and adalimumab (ADA) had significantly changed the course of inflammatory diseases such as rheumatoid arthritis (RA), spondyloarthritis (SpA) and Crohn's disease (CD). However, about 30% of patients do not respond to these treatments. This lack of response may be due to the formation of antibodies against these drugs (anti-drug antibodies: ADAbs). The aim of this study was to determine the prevalence of ADAbs against IFX and ADA, and the trough serum concentration of IFX and ADA in RA, SpA or CD patients and to assess their impact on the therapeutic response.

METHODS

A cross sectional, multi-centric study was conducted, including patients with RA, SpA or CD treated with IFX or ADA as a first biotherapy for at least 6 months. ADAbs and trough levels were measured by an Enzyme Linked Immunosorbent assay (ELISA).

RESULTS

197 patients were included (57 RA, 73 SpA and 67 CD). ADAbs were positive in 40% of cases for IFX and 25% for ADA. They were positive in 40% of SpA, 35% of RA, and 21% of CD. The presence of ADAbs was inversely correlated to the trough levels of IFX and ADA during RA (p = 0.01 and p < 0.0001), SpA (p < 0.01 and p < 0.0001) and CD (p = 0.001 and p = 0.04). For all pathologies, the presence of ADAbs was not correlated with disease activity. Concomitant methotrexate significantly reduced immunogenicity.

CONCLUSION

In our study, the presence of ADAb and low trough levels seem to not affect the therapeutic response in patients on TNF alpha antagonists. Other tracks more than immunogenicity should be investigated to explain the loss of response to these biotherapies.

Для цитирования: Bouden Selma, Laadhar Lilia, Soua Jihene, Ben Messaoud Meriam, Rouached Leila, Ayadi Imene, Saidane Olfa, Ben Tekaya Aicha, Mahmoud Ines, Rekik Sonia, Srairi Héla Sahli, Tekaya Rawdha, Bellakhal Syrine, Fekih Monia, Abdelmoula Leila, Kallel Maryem. No Correlation between Anti-drug Antibodies and Therapeutic Response in Tunisian Patients with Chronic Inflammatory Diseases Treated by TNF Blockers.. Current rheumatology reviews. 2024. DOI: 10.2174/0115733971257151230919095431.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.